Drugplain

Cuprum oxydatum nigrum 200 [kp_C]/200[kp_C]

CUPRIC OXIDE · PELLET · Boiron

No Recall History
Plain English

Cuprum oxydatum nigrum is a pellet containing cupric oxide at 200 [kp_C]/200[kp_C], taken oral. Manufactured by Boiron.

Key Facts

Brand Name
Cuprum oxydatum nigrum
Generic Name
CUPRIC OXIDE
NDC Code (Product)
0220-1620
Manufacturer
Boiron
Strength
200 [kp_C]/200[kp_C]
Dosage Form
PELLET
Route
ORAL
Marketing Status
Marketing Start
01/01/2024

Recall History

No Recall History

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

drug ineffective377 reports
macular degeneration369 reports
nausea117 reports
weight decreased116 reports
pain114 reports
therapeutic product effect incomplete114 reports
chronic sinusitis112 reports
malaise112 reports
paraesthesia oral112 reports
pyrexia112 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

Uses: See symptoms on front panel. Relieves nervousness in children *

Dosage & Administration

Adults and children: At the onset of symptoms, dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a doctor.

Frequently Asked Questions

What is Cuprum oxydatum nigrum used for?

Cuprum oxydatum nigrum contains CUPRIC OXIDE. It is a pellet taken oral. Consult your doctor for specific uses.

Is Cuprum oxydatum nigrum a controlled substance?

Cuprum oxydatum nigrum is not classified as a controlled substance by the DEA.

What is the generic name for Cuprum oxydatum nigrum?

The generic name for Cuprum oxydatum nigrum is CUPRIC OXIDE. There are no other listed brand versions of CUPRIC OXIDE.

What is the NDC code for Cuprum oxydatum nigrum 200 [kp_C]/200[kp_C]?

The NDC (National Drug Code) for Cuprum oxydatum nigrum 200 [kp_C]/200[kp_C] is 0220-1620, listed by Boiron.

Product NDC

0220-1620

Package NDC

0220-1620-41

Other Cuprum oxydatum nigrum Dosages

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)